# Efficacy of DA-5204 on Gastroesophageal Reflux Disease

> **NCT03998969** · PHASE3 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 70 (actual)

## Conditions studied

- Esophageal Disease

## Interventions

- **DRUG:** Pantoprazole
- **DRUG:** DA-5204
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03998969
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-01
- **Primary completion:** 2018-12-11
- **Final completion:** 2018-12-11
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2019-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03998969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03998969, "Efficacy of DA-5204 on Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03998969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*